Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

MYCOPHENOLATE 200 MG/ML SUSP

mycophenolate mofetil
$1.0410per ML

Strength

200 mg/mL

Manufacturer

Aurobindo Pharma Limited

NDC

59651064626

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

MYCOPHENOLATE MOFETIL

Approval Type

Generic (ANDA)

FDA Application

ANDA218227

On Market Since

9/26/2024

Pharmacological Classes

Antimetabolite Immunosuppressant

Price History

1W

0.0%

1M

-10.4%

3M

-11.5%

6M

-6.0%

1Y

-39.0%

3Y

N/A

5Y

N/A

All

-38.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

MYCOPHENOLIC ACID DR 180 MG TB
Generic
00904678504•Major Pharmaceuticals
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
00904678561•Major Pharmaceuticals
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
16729026129•Accord Healthcare Inc.
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
24979016044•TWi Pharmaceuticals, Inc.
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
59651062108•Aurobindo Pharma Limited
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
60505296507•Apotex Corp.
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
67877042612•Ascend Laboratories, LLC
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
68084090721•American Health Packaging
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
70377003911•Biocon Pharma Inc.
$0.1200
per EA
MYCOPHENOLIC ACID DR 180 MG TB
Generic
70377012611•Biocon Pharma Inc.
$0.1200
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy